Comparison of euploidy rates of blastocysts in women treated with progestins or GnRH antagonist to prevent the luteinizing hormone surge during ovarian stimulation
Author(s) -
Antonio La Marca,
Martina Capuzzo,
Sandro Sacchi,
Maria Giovanna Imbrogno,
Francesca Spinella,
Maria Teresa Varricchio,
Maria Giulia Minasi,
Pierfrancesco Greco,
Francesco Fiorentino,
Ermanno Greco
Publication year - 2020
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/deaa068
Subject(s) - progestin , stimulation , luteinizing hormone , oocyte , medicine , basal (medicine) , hormone antagonist , gonadotropin , gynecology , andrology , endocrinology , embryo , hormone , biology , endocrine system , insulin , microbiology and biotechnology
Does the prevalence of euploid blastocysts differ between patients treated with progestin primed ovarian stimulation (PPOS) and those treated with conventional ovarian stimulation?
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom